Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Pneumonia Clinical Trials

A listing of Pneumonia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (30) clinical trials

To evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 (amikacin inhalation solution) versus aerosolized placebo in the treatment of intubated and mechanically ventilated adult patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics

Phase

Are you at risk for pneumococcal disease?  If you are a smoker or have a chronic medical condition, you may be eligible for a clinical research study. Researchers are studying an investigational vaccine to see if it could help fight infections that can cause pneumococcal disease.  

Phase

For More Information Please Go To: https://virginiaresearchcenter.com/trials/c-diff/

Phase

Healthy Volunteers Needed Participate in a Pneumonia Vaccine Study Why should I participate? Serious pneumococcal disease may occur at any age. Adults of advanced age, with certain existing medical conditions, or weakened immune systems are at increased risk.  A clinical research study is evaluating an investigational vaccine to see how ...

Phase

Pneumococcal Vaccine Clinical Study Enrolling Now. This study will offer: Reimbursement for travel An investigational vaccine or an approved vaccine that may help prevent pneumococcal disease (including pneumonia and blood infection) Study-related medical care For ages 18 to 49. No health insurance or referrals required.  

Phase

PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone

Ventilation-associated pneumonia (VAP) is the main site of healthcare-associated infections in the brain injured patients, with an incidence rate of 22% to 58%. VAP increases morbi-mortality, length of stay in intensive care and overall management costs. The prevention of ICU nosocomial infections depends on several measures : orotracheal intubation route, ...

Phase

Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System

Sepsis is a condition with actually rising incidence, estimated around 19 cases per 1000 hospitalizations per year in academic hospitals in USA and similar trends in Europe. It is associated with unacceptably high early (in-hospital) mortality of 40- 50%. Current guidelines promote best practice by early recognition and management with ...

Phase

Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is a major event of IPF with an annual incidence between 5 and 10% and is responsible for the death of one third of IPF patients. When AE-IPF occurs, it is associated with poor survival with an overall mortality at 3 months upper ...

Phase

Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases

The purpose of the study is to evaluate the efficacy on lung function 6 months after one course of rituximab (2 infusions) and mycophnolate moftil (MMF) treatment compared to one course of placebo and 6 months of MMF treatment in a broad range of patients with Interstitial Lung Diseases (ILD) ...

Phase

Community-Acquired Pneumonia : Evaluation of Corticosteroids

Patients will receive state-of-the-art standard therapy for severe Community-Acquired Pneumonia (CAP), including antibiotics and supportive care. Correction of hypoxemia will use standard low-flow oxygen therapy, high-flow oxygen therapy, non-invasive-ventilation or invasive ventilation with endotracheal tube, as required. Patients in the treatment group will receive intra-venous hydrocortisone. Patients of the control ...

Phase